Eyenovia, Inc.
(NASDAQ : EYEN)

( )
EYEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
0.20%45.331.4%$886.97m
MRKMerck & Co., Inc.
1.55%74.600.6%$868.71m
PFEPfizer Inc.
1.13%39.420.9%$823.54m
JNJJohnson & Johnson
1.50%139.900.7%$815.75m
LLYEli Lilly and Company
1.74%117.481.0%$663.22m
ABBVAbbVie, Inc.
0.64%78.652.2%$407.28m
NVSNovartis AG Sponsored ADR
0.66%75.900.2%$278.63m
AZNAstraZeneca PLC Sponsored ADR
-0.16%38.691.3%$252.32m
GSKGlaxoSmithKline plc Sponsored ADR
1.34%40.210.2%$103.17m
NVONovo Nordisk A/S Sponsored ADR Class B
1.19%48.670.1%$67.15m
SNYSanofi Sponsored ADR
0.87%41.710.2%$36.01m
LCILannett Company, Inc.
-0.28%7.2036.7%$7.66m
AKTXAkari Therapeutics Plc Sponsored ADR
15.82%3.881.6%$5.73m
EPIXESSA Pharma Inc
-3.04%2.300.1%$0.03m

Company Profile

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The company was founded on March 12, 2014 and is headquartered in New York, NY.